Director Robert Schriesheim sells 5,000 Houlihan Lokey (HLI) shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Houlihan Lokey, Inc. director Robert A. Schriesheim reported selling 5,000 shares of Class A common stock on February 6, 2026, at a price of $170.86 per share. After this transaction, he beneficially owns 27,982 shares of Houlihan Lokey common stock, held in direct ownership.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 5,000 shares ($854,300)
Net Sell
1 txn
Insider
SCHRIESHEIM ROBERT A
Role
Director
Sold
5,000 shs ($854K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | CLASS A COMMON STOCK | 5,000 | $170.86 | $854K |
Holdings After Transaction:
CLASS A COMMON STOCK — 27,982 shares (Direct)
Footnotes (1)
FAQ
What insider transaction did HLI director Robert Schriesheim report?
Director Robert A. Schriesheim reported selling 5,000 shares of Houlihan Lokey Class A common stock. The sale occurred on February 6, 2026, and was reported on a Form 4 insider trading filing, which discloses changes in his beneficial ownership.
What role does Robert Schriesheim have at Houlihan Lokey (HLI)?
Robert A. Schriesheim is identified as a director of Houlihan Lokey, Inc. in the filing. The Form 4’s relationship section confirms his status as a director and indicates he is not reported as a 10% owner or officer of the company.
Who signed the Form 4 reporting the HLI insider transaction?
The Form 4 was signed by J. Lindsey Alley acting as Attorney-in-Fact for Robert Schriesheim. This indicates the filing was submitted under a power of attorney on February 9, 2026, as disclosed in the signature block.